News & Updates

Trabecular bone loss tied to ASDAS, inflammatory markers in axial spondyloarthritis

07 Sep 2020

Trabecular bone loss is longitudinally associated with Ankylosing Spondylitis Disease Activity Score (ASDAS) and inflammatory markers in patients with axial spondyloarthritis (axSpA), a study has found.

Trabecular bone loss tied to ASDAS, inflammatory markers in axial spondyloarthritis

07 Sep 2020

Pain, fatigue may persist in PsA despite biologic therapy

06 Sep 2020

Some psoriatic arthritis (PsA) patients still experience substantial pain and fatigue despite treatment, a study has shown. These persisting conditions negatively affect health-related quality of life (HRQoL), physical function, and work productivity.

Pain, fatigue may persist in PsA despite biologic therapy

06 Sep 2020

Systemic JIA: Tapering canakinumab feasible in children in complete remission

03 Sep 2020

For paediatric patients who achieved complete remission (CR) on canakinumab, it is possible to maintain this response while reducing exposure to the drug, as shown in a study.

Systemic JIA: Tapering canakinumab feasible in children in complete remission

03 Sep 2020

Long-term methotrexate therapy may be discontinued in stable RA patients

02 Sep 2020 by

More than half of rheumatoid arthritis (RA) patients achieving low disease activity on long-term methotrexate (MTX) remain flare-free following its withdrawal, as shown in a study. The use of a higher MTX dose to preserve low disease activity is predictive of disease flare after discontinuation.

Long-term methotrexate therapy may be discontinued in stable RA patients

02 Sep 2020

Aggressive treatment needed in Takayasu arteritis patients with severe ischaemic events

27 Aug 2020

Patients with Takayasu arteritis (TA) are at greater risk of experiencing severe ischaemic events (SIEs), which occur early in the disease, according to a study, adding that aggressive treatment can lead to a favourable prognosis in this population.

Aggressive treatment needed in Takayasu arteritis patients with severe ischaemic events

27 Aug 2020

Elevated lupus risk seen in allergic rhinitis patients

27 Aug 2020

Patients with allergic rhinitis may risk developing systemic lupus erythematosus (SLE), according to the results of a systematic review and meta-analysis.

Elevated lupus risk seen in allergic rhinitis patients

27 Aug 2020

SSc linked to increased complications, healthcare use after THA

26 Aug 2020

Systemic sclerosis (SSc) contributes to higher in-hospital complications and healthcare use following primary total hip arthroplasty (THA), reveal the results a recent study.

SSc linked to increased complications, healthcare use after THA

26 Aug 2020

3-month exercise regimen provides long-term benefits on physical activity in axSpA

25 Aug 2020

An exercise programme lasting for 3 months has been shown to confer positive long-term effects on leisure time physical activity in individuals with axial spondyloarthritis (axSpA), indicating a more favourable health profile, according to a study.

3-month exercise regimen provides long-term benefits on physical activity in axSpA

25 Aug 2020

Roflumilast cream may reduce severity of plaque psoriasis

25 Aug 2020 by

Use of the topical PDE-4* inhibitor roflumilast led to greater reductions in the signs and symptoms of chronic plaque psoriasis compared with placebo, a phase IIb trial has shown.

Roflumilast cream may reduce severity of plaque psoriasis

25 Aug 2020

Febuxostat carries no excess risks of death, adverse CV outcomes

24 Aug 2020

In the treatment of patients with gout and hyperuricemia, use of febuxostat does not appear to come with an increased hazard of mortality or adverse cardiovascular (CV) outcomes, according to the results of a meta-analysis.

Febuxostat carries no excess risks of death, adverse CV outcomes

24 Aug 2020

News & Updates

Filter by Specialty:

Specialty:

Trabecular bone loss tied to ASDAS, inflammatory markers in axial spondyloarthritis

Trabecular bone loss tied to ASDAS, inflammatory markers in axial spondyloarthritis

Pain, fatigue may persist in PsA despite biologic therapy

Pain, fatigue may persist in PsA despite biologic therapy

Systemic JIA: Tapering canakinumab feasible in children in complete remission

Systemic JIA: Tapering canakinumab feasible in children in complete remission

Long-term methotrexate therapy may be discontinued in stable RA patients

Long-term methotrexate therapy may be discontinued in stable RA patients

Aggressive treatment needed in Takayasu arteritis patients with severe ischaemic events

Aggressive treatment needed in Takayasu arteritis patients with severe ischaemic events

Elevated lupus risk seen in allergic rhinitis patients

Elevated lupus risk seen in allergic rhinitis patients

SSc linked to increased complications, healthcare use after THA

SSc linked to increased complications, healthcare use after THA

3-month exercise regimen provides long-term benefits on physical activity in axSpA

3-month exercise regimen provides long-term benefits on physical activity in axSpA

Roflumilast cream may reduce severity of plaque psoriasis

Roflumilast cream may reduce severity of plaque psoriasis

Febuxostat carries no excess risks of death, adverse CV outcomes

Febuxostat carries no excess risks of death, adverse CV outcomes